Ratification Date: 01/04/2025

Next Review Date: 01/04/2027

Gemcitabine – Non-small cell lung carcinoma

Drug Name (Brand) Gemcitabine  (Gemzar®)
Indication Non-small cell lung carcinoma
Traffic Light Classification Red
NICE TA (plus link)  
Further Information:

NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.

 

NHS England Specialised Commissioning responsibility from April 2013.

 

November 2013: NICE treatment pathway for lung cancer: http://pathways.nice.org.uk/pathways/lung-cancer

 

 

 

 

Date of TAG recommendation / ratification 11/1/2013 Review Date 1/4/2027